IL122012A - Process for the separation of mixtures of enantiomers with optically active resolving agents from a diastereomeric complex - Google Patents

Process for the separation of mixtures of enantiomers with optically active resolving agents from a diastereomeric complex

Info

Publication number
IL122012A
IL122012A IL12201297A IL12201297A IL122012A IL 122012 A IL122012 A IL 122012A IL 12201297 A IL12201297 A IL 12201297A IL 12201297 A IL12201297 A IL 12201297A IL 122012 A IL122012 A IL 122012A
Authority
IL
Israel
Prior art keywords
optically active
enantiomers
mixtures
separation
complex
Prior art date
Application number
IL12201297A
Other languages
English (en)
Other versions
IL122012A0 (en
Original Assignee
Dsm Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Nv filed Critical Dsm Nv
Publication of IL122012A0 publication Critical patent/IL122012A0/xx
Publication of IL122012A publication Critical patent/IL122012A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/023Preparation; Separation; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/80Preparation of compounds containing amino groups bound to a carbon skeleton by photochemical reactions; by using free radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/34Preparation of optical isomers by separation of optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • C07C253/34Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/487Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
IL12201297A 1996-10-23 1997-10-21 Process for the separation of mixtures of enantiomers with optically active resolving agents from a diastereomeric complex IL122012A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1004346A NL1004346C2 (nl) 1996-10-23 1996-10-23 Werkwijze voor het scheiden van een mengsel van enantiomeren in een geschikt oplosmiddel.

Publications (2)

Publication Number Publication Date
IL122012A0 IL122012A0 (en) 1998-03-10
IL122012A true IL122012A (en) 2001-08-26

Family

ID=19763731

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12201297A IL122012A (en) 1996-10-23 1997-10-21 Process for the separation of mixtures of enantiomers with optically active resolving agents from a diastereomeric complex

Country Status (11)

Country Link
US (1) US6235927B1 (de)
EP (1) EP0838448B1 (de)
JP (1) JPH10245368A (de)
CN (1) CN1182068A (de)
AT (1) ATE264826T1 (de)
CA (1) CA2218804A1 (de)
DE (1) DE69728730T9 (de)
IL (1) IL122012A (de)
IN (1) IN184142B (de)
NL (1) NL1004346C2 (de)
NO (1) NO974779L (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056740A1 (de) * 1998-02-20 2000-12-06 Fine Chemicals Corporation (Proprietary) Limited Verfahren zu der erzeugung von optsch anreicherne (r)- oder (s)- albuterol
US6713627B2 (en) 1998-03-13 2004-03-30 Aventis Pharmaceuticals Inc. Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
NL1008911C2 (nl) * 1998-04-17 1999-10-19 Dsm Nv Werkwijze voor het verhogen van de enantiomere overmaat van een chirale verbinding.
EP1034826A1 (de) * 1999-03-05 2000-09-13 Reuter Chemische Apparatebau Co-Kristallisationsverfahren
NL1012865C2 (nl) * 1999-08-19 2001-02-20 Dsm Nv 1-Fenyl-3-oxopropaan-1-sulfonzuren en -sulfonaten en zuivere enantiomeren daarvan.
AU7949900A (en) * 1999-10-22 2001-05-08 Takeda Chemical Industries Ltd. Process for producing optically active naphthalene derivative and optical resolver therefor
US7666588B2 (en) * 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
JP2005104895A (ja) * 2003-09-30 2005-04-21 Nippon Kayaku Co Ltd 光学活性なアミノアルコール化合物の製造法
EP1692084B1 (de) * 2003-12-10 2007-05-09 Degussa GmbH Verfahren zur herstellung von enantiomeren angereicherten aminosäuren
EP1720861A2 (de) 2004-02-25 2006-11-15 Eli Lilly And Company Antagonisten des histamin-h3-rezeptors, herstellung und therapeutische anwendungen
WO2006006071A1 (en) * 2004-07-07 2006-01-19 Pfizer Products Inc. Resolution of an aryl-fused azapolycyclic compound
WO2007004077A2 (en) * 2005-05-04 2007-01-11 Medichem, S.A. Process for the preparation of tamsulosin
ATE523488T1 (de) 2005-07-01 2011-09-15 Lilly Co Eli Histamin-h3-rezeptor-mittel, deren herstellung und therapeutische verwendung
PL1951658T3 (pl) 2005-11-17 2013-02-28 Lilly Co Eli Antagoniści receptora glukagonu, preparatyka i zastosowania terapeutyczne
PT1951659E (pt) 2005-11-18 2010-09-10 Lilly Co Eli Antagonistas do receptor do glucagon, preparação e utilizações terapêuticas
UA99284C2 (ru) 2007-05-11 2012-08-10 Елі Ліллі Енд Компані ИНГИБИТОРЫ р70 S6-КИНАЗЫ
JP5901292B2 (ja) 2008-07-29 2016-04-06 ポクセル・エスアーエスPoxelsas 粒子サイズ制御結晶化による鏡像異性体混合物からの鏡像異性体成分の単離方法
AR075988A1 (es) 2009-04-09 2011-05-11 Lilly Co Eli Compuesto de piridiloxi - pirrolidina inhibidor de recaptacion de serotonina y norepinefrina, composicion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de dolor cronico
JP5581390B2 (ja) 2009-10-23 2014-08-27 イーライ リリー アンド カンパニー Akt阻害剤
CN101792398B (zh) * 2010-03-09 2013-06-26 河北科技大学 一种拆分法制备光学纯对羟基苯甘氨酸的方法
CN104876856B (zh) * 2015-05-05 2017-11-21 河北凯力昂生物科技有限公司 一种拆分法制备(r)‑(+)‑3‑氨基哌啶二盐酸盐的方法
CN104829459B (zh) * 2015-05-06 2017-05-24 河北凯力昂生物科技有限公司 一种拆分法制备(r)‑(+)‑1‑萘乙胺的方法
KR102565407B1 (ko) * 2016-01-04 2023-08-10 (주)아모레퍼시픽 극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법
CN108658784B (zh) * 2018-04-26 2020-12-18 联化科技股份有限公司 (r)-1-(4-甲基苯基)乙胺的合成方法
CN109485561A (zh) * 2018-11-23 2019-03-19 江苏颖盛化工有限公司 一种dl-萘普生的合成工艺
EP4045615A4 (de) * 2019-10-16 2023-12-20 Hikal Limited Industrieverfahren zur auflösung von chlocyphos
WO2024014282A1 (ja) * 2022-07-14 2024-01-18 株式会社クレハ トリアゾール誘導体のエナンチオマー(r)体の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB656500A (en) * 1947-10-24 1951-08-22 Sterling Drug Inc Improvements in or relating to the preparation of l-arterenol and l-arterenol so prepared
US3862985A (en) * 1971-07-28 1975-01-28 Allied Chem Resolution of lysineamide
US4642205A (en) * 1984-03-01 1987-02-10 Alkaloida Vegyeszeti Gyar Diastereomer salts of phenylalanine and N-acyl derivatives thereof and process for the separation of optically active phenylalanine and N-acyl derivatives thereof

Also Published As

Publication number Publication date
EP0838448A1 (de) 1998-04-29
DE69728730T2 (de) 2005-03-31
NL1004346C2 (nl) 1998-04-24
IN184142B (de) 2000-06-17
NO974779L (no) 1998-04-24
ATE264826T1 (de) 2004-05-15
DE69728730T9 (de) 2005-09-08
EP0838448B1 (de) 2004-04-21
JPH10245368A (ja) 1998-09-14
DE69728730D1 (de) 2004-05-27
US6235927B1 (en) 2001-05-22
CA2218804A1 (en) 1998-04-23
CN1182068A (zh) 1998-05-20
IL122012A0 (en) 1998-03-10
NO974779D0 (no) 1997-10-16

Similar Documents

Publication Publication Date Title
IL122012A (en) Process for the separation of mixtures of enantiomers with optically active resolving agents from a diastereomeric complex
DE69033355T2 (de) Imidazochinoxalinone, ihre Azaanaloge und Verfahren zu ihrer Herstellung
DE69333675D1 (de) Enzymatische Verfahren zur Aüftrennüng von Enantiomeren-Mischungen nützlich als Zwischenprodukte zur Herstellung von Taxanen
GB2299082B (en) An enantioselective process for the preparation of chiral triaryl
DK0787115T3 (da) Fremgangsmåde til fremstilling af 4a,5,9,10,11,12-hexahydro-6H-benzofuro[3a,3,2-ef][2]benzazepinderivater
CA2245768A1 (en) Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride
MX209701B (es) Proceso para la preparacion de d-treo-(r,r)-metil fenidato y recirculacion de enantiomeros no deseados a traves de epimerizacion.
IT8922075A0 (it) Processo per l'inversione stereochimica di (2s,3s)-2-ammino-3-fenil-1 ,3-propandioli nei corrispondenti enantiomeri (2r,3r)
DE69502675D1 (de) Verfahren zur Herstellung von Bis(Aminomethyl)Cyclohexan
ATE321773T1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
DE69300551D1 (de) Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid.
BG104240A (en) Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
DE59407675D1 (de) Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on
CA2084137A1 (en) Optically active bead polymers containing fillers
MY132710A (en) Method for separating an imine from a mixture containing an amine and an imine
CA2004554A1 (en) Novel(-)-2-pyrazoline compound, optical resolution of the same, and therapeutic agent for cerebrovascular disorders containing the same as effective ingredient
NO20000995D0 (no) Optisk rene camptotecin analoger, optisk rent mellomprodukt, fremgangsmõte for fremstilling av disse
DE69735977D1 (de) Einarbeitung von aromatischen polycyclischen Verbindungen während Chinacridonherstellungsverfahren
DK93190D0 (da) Fremgangsmaade til fremstilling af en iodaromatisk forbindelse
DK0431305T3 (da) Fremgangsmåde til fremstilling af molluskicide 2,4,5-tribrompyrrol-3-carbonitriler
DE59005407D1 (de) Verfahren zur Herstellung von faserreaktiven Formazanverbindungen.
EP0841318A3 (de) Optische Isomere von Derivaten von Kampholenaldehyd
DE59812729D1 (de) Verfahren zur Herstellung von 1,3-Dioxanverbindungen
DE19983723T1 (de) Verfahren zur Herstellung von Bis-N-substituierten Perylentetracarboximiden über Bis(hydroxymethyl)perylentetracarboximid
FR2707986B1 (fr) Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees